Evidence map›Paper›PMID 33574619›Full record

ArticleNature immunology2021

BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8

Chen Yao, Guohua Lou, Hong-Wei Sun, Ziang Zhu, Yi Sun, Zeyu Chen, Daniel Chauss, E Ashley Moseman, Jun Cheng, Marc A D'Antonio and 12 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 123 papers.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 188 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Journal for immunotherapy of cancer · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. DADA Enhances CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Regulators of CD8Nature reviews. Immunology · 2026
    Review
  19. Article
  20. The Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 3 countries.

Chen Yao *Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA. chen.yao2@nih.gov.ORCID http://orcid.org/0000-0001-6852-5661
Guohua Lou *Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Hong-Wei SunMolecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-9765-6505
Ziang ZhuDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Yi SunDepartment of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Zeyu ChenDepartment of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School Medicine, Philadelphia, PA, USA.
Daniel ChaussImmunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
E Ashley MosemanDepartment of Immunology, Duke University School of Medicine, Durham, NC, USA.
Jun ChengNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Marc A D'AntonioDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Wangke ShiDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Junwei ShiDepartment of Cancer Biology, University of Pennsylvania Perelman School Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-8427-6316
Kohei KometaniLaboratory of Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.
Tomohiro KurosakiLaboratory of Lymphocyte Differentiation, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan.ORCID http://orcid.org/0000-0002-6352-304X
E John WherryDepartment of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-0477-1956
Behdad AfzaliImmunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Luca GattinoniRegensburg Center for Interventional Immunology, University of Regensburg, Regensburg, Germany.ORCID http://orcid.org/0000-0003-2239-3282
Yuwen ZhuDepartment of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Dorian B McGavernViral Immunology and Intravital Imaging Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-9568-545X
John J O'SheaMolecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
Pamela L SchwartzbergNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Tuoqi WuDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. tuoqi.wu@cuanschutz.edu.ORCID http://orcid.org/0000-0002-4003-1034
National Institutes of Health · USUniversity of Colorado Anschutz Medical Campus · USRIKEN Center for Integrative Medical Sciences · JPTranslational Therapeutics (United States) · USDuke University · USUniversity of Pennsylvania · USUniversity of Regensburg · DE

Funding

Stat transcription factors in immunoregulation and autoimmune diseaseZIAAR041159 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2009 to 2025
$49.3M
Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI E. John Wherry · 2009 to 2026
$48.1M
Pathogenesis of viral meningitisZIANS003112 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI MCGAVERN, DORIAN · 2009 to 2025
$33.6M
Mechanisms Underlying Clearance of the Persistently Infected CNSZIANS003111 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI MCGAVERN, DORIAN · 2009 to 2025
$33.0M
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunityP01AI108545 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI E. John Wherry · 2015 to 2026
$30.8M
NHGRI/DIR Embryonic Stem Cell and Transgenic Mouse CoreZICHG200349 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BURGESS, SHAWN M · 2010 to 2025
$23.8M
Unravelling immunoregulatory circuits of tissue inflammationZIADK075149 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI AFZALI, BEHDAD · 2019 to 2025
$19.3M
Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte SignalingZIAAI001240 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SCHWARTZBERG, PAMELA · 2019 to 2025
$18.8M
Sequencing and Viral Evolution CoreU19AI117950 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WHERRY, E. JOHN · 2015 to 2019
$12.0M
Radiation and checkpoint blockade for cancer immune therapyP01CA210944 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KOUMENIS, CONSTANTINOS · 2017 to 2022
$11.5M
P3: Chemokine-Mediated T Cell Trafficking in HIV Transmission and Immune ResponseP01AI112521 · NIAID · HARVARD MEDICAL SCHOOL · PI LUSTER, ANDREW · 2014 to 2018
$9.8M
Programming T Cell Fates for Therapeutic UseZIABC011480 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GATTINONI, LUCA · 2013 to 2019
$7.4M
Intramural NIH HHS ZIA AI001240Intramural NIH HHS ZIA AI001241Intramural NIH HHS ZIA AR041106Intramural NIH HHS ZIA AR041159Intramural NIH HHS ZIA AR041167Intramural NIH HHS ZIA BC011480Intramural NIH HHS ZIA DK075149Intramural NIH HHS ZIA NS003111Intramural NIH HHS ZIA NS003112NCI NIH HHS F99 CA234842NCI NIH HHS K00 CA234842NCI NIH HHS P01 CA210944NIAID NIH HHS P01 AI108545NIAID NIH HHS P01 AI112521NIAID NIH HHS R01 AI105343NIAID NIH HHS R01 AI115712NIAID NIH HHS U19 AI082630NIAID NIH HHS U19 AI117950NIA NIH HHS K99 AG056524NIA NIH HHS R00 AG056524
6 · The paper itself

Abstract

During chronic infection and cancer, a self-renewing CD8

Indexed as

Cell DifferentiationEpigenesis, GeneticTranscription, GeneticAnimalsArenaviridae InfectionsBasic-Leucine Zipper Transcription FactorsCD8-Positive T-LymphocytesCell LineageCells, CulturedChronic DiseaseDisease Models, AnimalHost-Pathogen InteractionsLymphocytic choriomeningitis virusMiceMice, Inbred C57BLMice, KnockoutBach2 protein, mouseBasic-Leucine Zipper Transcription Factors

Identifiers

PMID33574619
PMCPMC7906956
OpenAlexW3126762896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.